The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will ...
Heikki Lanckriet became the CEO of Expedeon AG (ETR:EXNN) in 2017. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Then we'll look ...
Expedeon AG has announced that the Company’s Extraordinary General Meeting (EGM) held in Heidelberg today has approved all management proposals by a large majority without objection. The EGM was held ...
Expedeon AG, today announced it has signed a supply and license agreement with Cell Guidance Systems, a developer of therapeutic products for medicine and life science research, for use of Expedeon’s ...
CAMBRIDGE, England, Jan. 6, 2020 /PRNewswire/ -- Abcam plc, a global innovator in life science reagents and tools, is pleased to announce the successful completion of the acquisition of Expedeon's ...
Expedeon AG announced today it has introduced Lightning-Link ® Metal Labeling Kits for use in multiple immunoassay-based applications to support single cell analysis. The new kits will enable users to ...
Joint portfolio includes protein analysis and purification solutions. Expedeon and Protein Discovery have decided to come together to create a supplier of products for protein research. The new ...
Heidelberg, Germany and Cambridge, UK, 19 December 2019 - Expedeon AG (Frankfurt: EXNN; ISIN: DE000A2YN801; Prime Standard) today announced that the Company's Extraordinary General Meeting (EGM) held ...
Sygnis said today it plans to acquire Expedeon Holdings, a developer, manufacturer, and commercializer of proteomics reagents and tools. Expedeon’s protein research offerings include RunBlue ® gels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results